State of Wisconsin Investment Board’s Corbus Pharmaceuticals CRBP Stock Holding History

State of Wisconsin Investment Board’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,566	Closed	-$290K	–	2263
2024 Q4	$290K	Buy	24,566 +13,183	+116%	+$221K	﹤0.01%	2019
2024 Q3	$235K	Buy	+11,383	New	+$583K	﹤0.01%	2124
2020 Q4	–	Sell	-3,057	Closed	-$165K	–	1990
2020 Q3	$165K	Hold	3,057	–	–	﹤0.01%	1926
2020 Q2	$769K	Hold	3,057	–	–	﹤0.01%	1302
2020 Q1	$480K	Buy	3,057 +90	+3%	+$15.2K	﹤0.01%	1361
2019 Q4	$486K	Hold	2,967	–	–	﹤0.01%	1455
2019 Q3	$433K	Buy	2,967 +544	+22%	+$94.8K	﹤0.01%	1374
2019 Q2	$504K	Buy	2,423 +53	+2%	+$11.3K	﹤0.01%	1323
2019 Q1	$494K	Buy	2,370 +663	+39%	+$146K	﹤0.01%	1347
2018 Q4	$299K	Buy	1,707 +640	+60%	+$128K	﹤0.01%	1413
2018 Q3	$242K	Hold	1,067	–	–	﹤0.01%	1486
2018 Q2	$162K	Hold	1,067	–	–	﹤0.01%	1436
2018 Q1	$195K	Hold	1,067	–	–	﹤0.01%	1403
2017 Q4	$227K	Hold	1,067	–	–	﹤0.01%	1383
2017 Q3	$229K	Hold	1,067	–	–	﹤0.01%	1391
2017 Q2	$202K	Buy	+1,067	New	+$209K	﹤0.01%	1401

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State of Wisconsin Investment Board's CRBP Position: Q1 2025 in Review

State of Wisconsin Investment Board sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 24,566 shares — an estimated $290K sold.

State of Wisconsin Investment Board first reported a position in CRBP in Q2 2017 and held it in 16 quarters. The position peaked at $769K in Q2 2020. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

State of Wisconsin Investment Board reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
State of Wisconsin Investment Board sold 24,566 Corbus Pharmaceuticals shares in Q1 2025, an estimated $290K.
State of Wisconsin Investment Board first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 16 quarters.
State of Wisconsin Investment Board's Corbus Pharmaceuticals position peaked at $769K in Q2 2020.
86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.